Serum albumin, genetic susceptibility, and risk of venous thromboembolism

被引:1
|
作者
Sun, Yuyang [1 ]
Deng, Jun [1 ]
Ding, Yajie [1 ]
Luo, Shanshan
Li, Si
Guan, Yunlong [2 ]
Cao, Xi [2 ]
Hao, Xingjie [2 ]
Hu, Yu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, 1277,Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China
关键词
NEPHROTIC SYNDROME; THROMBOSIS; INFLAMMATION; ASSOCIATION; POPULATION; PREDICTORS; MORTALITY; EVENTS;
D O I
10.1016/j.rpth.2024.102509
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous research on the association between serum albumin (ALB) and venous thromboembolism (VTE) has produced inconclusive results. The polygenic risk score is constructed from a set of independent risk variants associated with a disorder, enabling the identification of a larger fraction of the population at comparable or greater disease risk. It is still unknown whether ALB and genetic factors jointly contribute to the incidence of VTE. Objectives: The present study aimed to explore ALB, genetic susceptibility, and the risk of VTE. Methods: The present investigation was an analysis of prospectively collected data from UK Biobank, a population-based, longitudinal cohort. Cox proportional models were used to calculate hazard ratios and 95% CIs for VTE. The Kaplan-Meier curve was utilized to visualize the cumulative risk of VTE according to different serum ALB levels, and the restricted cubic spline model was leveraged to explore the exposure-response relationship among ALB levels and VTE risk. Results: During median follow-up of 13.5 years, 11,502 cases with VTE were diagnosed among 417,113 participants in the UK Biobank. The lower ALB levels were associated with a higher risk for VTE. Individuals with both a high genetic risk and lowest ALB level had the highest risk of VTE (hazard ratio, 3.89; 95% CI, 3.41-4.43), compared with those with low genetic risk and highest ALB level. The positive joint effects of low ALB and polygenic risk score increased the risk of VTE in individuals with high genetic risk. This study excluded non-European patients and primarily focused on the European population, which may limit the generalizability of the findings. Conclusion: Low serum ALB levels were linked to an increased risk of VTE, which was in accordance with a linear dose-response relationship. There was a positive additive effect of ALB and genetic susceptibility on the risk of VTE. ALB could serve as a biomarker for predicting the risk of VTE.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] RISK OF VENOUS THROMBOEMBOLISM COMPLICATIONS ASSOCIATED WITH RECURRENT VENOUS THROMBOEMBOLISM
    Lefebvre, P.
    Laliberte, F.
    Nutescu, E.
    Duh, M. S.
    LaMori, J. C.
    Bookhart, B.
    Olson, W. H.
    Dea, K.
    Hossou, Y.
    Schein, J. R.
    Kaatz, S.
    VALUE IN HEALTH, 2013, 16 (03) : A184 - A184
  • [32] Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial
    Chi, Gerald
    Gibson, C. Michael
    Liu, Yuyin
    Hernandez, Adrian F.
    Hull, Russell D.
    Cohen, Alexander T.
    Harrington, Robert A.
    Goldhaber, Samuel Z.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : 21 - 28
  • [33] Risk of Venous Thromboembolism Complications Associated with Recurrent Venous Thromboembolism
    Lefebvre, Patrick
    Laliberte, Francois
    Nutescu, Edith
    Duh, Mei Sheng
    LaMori, Joyce C.
    Bookhart, Brahim K.
    Olson, William H.
    Dea, Katherine
    Hossou, Yvonnick
    Schein, Jeff R.
    Kaatz, Scott
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 432 - 433
  • [34] Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein
    Kunutsor, Setor K.
    Seidu, Samuel
    Katechia, Devvrat T.
    Laukkanen, Jari A.
    ANNALS OF MEDICINE, 2018, 50 (03) : 240 - 248
  • [35] Serum osteoprotegerin and future risk of venous thromboembolism. The Tromso study
    Vik, Anders
    Brodin, Ellen
    Brkkan, Sigrid K.
    Hansen, John-Bjarne
    THROMBOSIS RESEARCH, 2012, 130 (04) : E236 - E237
  • [36] A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
    Lixian Ji
    Peng Shu
    Arthritis Research & Therapy, 25
  • [37] A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
    Ji, Lixian
    Shu, Peng
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [38] Family history of venous thromboembolism as a risk factor and genetic research tool
    Zoller, Bengt
    Li, Xinjun
    Ohlsson, Henrik
    Ji, Jianguang
    Sundquist, Jan
    Sundquist, Kristina
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (05) : 890 - 900
  • [39] Genetic Risk Score for Height and the Incidence of Venous Thromboembolism: A Prospective Study
    Roetker, Nicholas S.
    Pankow, James S.
    Lutsey, Pamela L.
    Tang, Weihong
    Rosenberg, Michael A.
    Heckbert, Susan R.
    Cushman, Mary
    Folsom, Aaron R.
    CIRCULATION, 2016, 133
  • [40] Replication of a genetic risk score for venous thromboembolism in whites but not in African Americans
    Folsom, A. R.
    Tang, W.
    Weng, L. -C.
    Roetker, N. S.
    Cushman, M.
    Basu, S.
    Pankow, J. S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (01) : 83 - 88